Terumo Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRUMY research report →
About the company
Terumo Corporation is a global medical technology company dedicated to the manufacturing and sale of a wide array of medical products and equipment, operating through three distinct business segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular division provides critical devices for cardiovascular and cerebrovascular interventions, including angiographic guidewires, various catheters (angiographic, PTCA balloon, imaging), introducer sheaths, vascular closure devices, coronary and self-expanding peripheral stents, and intravascular ultrasound systems; it also develops specialized tools for cerebral aneurysm treatment like coils, stents, and intrasaccular devices, as well as embolization systems, aspiration catheters, and clot retrievers for ischemic stroke, further supplying oxygenators, cardio-pulmonary bypass systems, and artificial vascular and stent grafts. The Medical Care Solutions segment offers a comprehensive range of general medical products such as syringes, infusion and syringe pumps, infusion lines, I.
- CEO
- Hikaru Samejima
- IPO
- 2010
- Employees
- 30,207
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $20.22B
- P/E
- 24.51
- P/S
- 2.94
- P/B
- 2.10
- EV/EBITDA
- 12.37
- Div Yield
- 1.33%
- Gross Margin
- 52.54%
- Op Margin
- 16.32%
- Net Margin
- 12.01%
- ROE
- 9.19%
- ROIC
- 6.87%
- Revenue
- $1.20T · 15.82%
- Net Income
- $144.11B · 23.19%
- EPS
- $97.47 · 23.36%
- Op Income
- $195.88B
- FCF YoY
- 20.23%
- 52W High
- $19.60
- 52W Low
- $12.08
- 50D MA
- $13.60
- 200D MA
- $14.38
- Beta
- 0.21
- Avg Volume
- 200.00K
Get TickerSpark's AI analysis on TRUMY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TRUMY coverage
Recent articles, reports, and earnings notes.
No research on TRUMY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRUMY report →Similar companies
Peers in the same neighborhood.